Literature DB >> 30261188

Lipoproteins from vertebrate host blood plasma are involved in Trypanosoma cruzi epimastigote agglutination and participate in interaction with the vector insect, Rhodnius prolixus.

Carlos José De Carvalho Moreira1, Nuccia Nicole Theodoro De Cicco2, Tainah Silva Galdino3, Denise Feder4, Marcelo Salabert Gonzalez4, Renata Bortolasse Miguel1, José Rodrigues Coura1, Helena Carla Castro5, Patricia Azambuja6, Georgia Corrêa Atella2, Norman Arthur Ratcliffe7, Cicero Brasileiro Mello8.   

Abstract

Chagas disease, infecting ca. 8 million people in Central and South America, is mediated by the protozoan parasite, Trypanosoma cruzi. The parasite is transmitted by the bite of blood sucking triatomine insects, such as Rhodnius prolixus, that had previously fed on parasite-infected vertebrate blood and voided their contaminated feces and urine into the wound. The stages of the parasite life cycle in both the insect vector and human host are well-known, but determinants of infection in the insect gut are complex and enigmatic. This paper examines the possible role of the R. prolixus gut agglutinins in the parasite life cycle. The results, derived from gut extracts made from R. prolixus fed on various diets with different vertebrate blood components, and cross adsorption experiments, showed for the first time that R. prolixus has two distinct gut agglutinins originating from their vertebrate blood meal, one for T. cruzi (the parasite agglutinin, PA) and the other for the erythrocytes (the hemagglutinin, HA). Again, uniquely, the results also demonstrate that these two agglutinins are derived, respectively, from the plasma and erythrocyte components of the vertebrate blood. Subsequent experiments, examining in more detail the nature of the plasma components forming the T. cruzi PA, used fractionated extracts of the vertebrate plasma (high density lipoprotein, HDL; low density lipoprotein, LDL, and delipidated plasma) in agglutination assays. The results confirmed the identity of the PA as a high density lipoprotein (HDL) in the plasma of the vertebrate blood meal which agglutinates parasites in the R. prolixus gut. In addition, the use of single or double labeled HDL in fluorescence and confocal microscopy showed the interaction of the labeled HDL with the parasite surface and its internalization at later times. Finally, results of T. cruzi parasitization of R. prolixus, incorporating various vertebrate blood components, resulted in highly significant increases in infectivity in the presence of HDL from the 2nd day of infection, thus confirming the important role of this molecule in T. cruzi infection of R. prolixus.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Agglutination; Cruzipain; HDL; Infection; Plasma; Rhodnius prolixus; Trypanosoma cruzi

Mesh:

Substances:

Year:  2018        PMID: 30261188     DOI: 10.1016/j.exppara.2018.09.017

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  3 in total

1.  Trypanosoma cruzi surface mucins are involved in the attachment to the Triatoma infestans rectal ampoule.

Authors:  María de Los Milagros Cámara; Virginia Balouz; Camila Centeno Cameán; Carmen R Cori; Gustavo A Kashiwagi; Santiago A Gil; Natalia Paula Macchiaverna; Marta Victoria Cardinal; Francisco Guaimas; Maite Mabel Lobo; Rosa M de Lederkremer; Carola Gallo-Rodriguez; Carlos A Buscaglia
Journal:  PLoS Negl Trop Dis       Date:  2019-05-20

2.  Proteome of the Triatomine Digestive Tract: From Catalytic to Immune Pathways; Focusing on Annexin Expression.

Authors:  Marcia Gumiel; Debora Passos de Mattos; Cecília Stahl Vieira; Caroline Silva Moraes; Carlos José de Carvalho Moreira; Marcelo Salabert Gonzalez; André Teixeira-Ferreira; Mariana Waghabi; Patricia Azambuja; Nicolas Carels
Journal:  Front Mol Biosci       Date:  2020-12-09

Review 3.  Lipid hijacking: a unifying theme in vector-borne diseases.

Authors:  Anya J O'Neal; L Rainer Butler; Agustin Rolandelli; Stacey D Gilk; Joao Hf Pedra
Journal:  Elife       Date:  2020-10-29       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.